Breast cancer
Conditions
Interventions
Control group:Without Ultrasonic treatment
Experimental group:diagnostic ultrasound combined with ultrasound microbubbles
Sponsors
Hubei Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) A patient confirmed to be breast cancer by histopathology; (2) female aged 18-75 years old; (3) Oncological assessment (ultrasound, CT or MRI) with measurable and evaluable individual tumor lesions; (4) The estimated survival time is more than 5 months; the PS score is 0-2 points; (5) Blood routine examination: WBC (white blood cells) >=3.5x10^9/L, ANC (neutrophils) >=1.5x10^9/L, PLT (platelets) = 80x10^9/L, Hb (hemoglobin) >=90g/L; (6) There is no obvious abnormality in liver and kidney function: ALT (alanine aminotransferase), AST (aspartate aminotransferase) <=2.5 times the upper limit of normal value, Urea (urea), Crea (creatinine) <=upper limit of normal value 1.25 times, the upper limit of ALT, AST <=normal value of patients with liver metastasis is 5 times; (7) Cardiopulmonary function is basically normal; (8) No history of other malignant tumors; (9) Good compliance and no mental disorders; (10) Sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Does not meet the inclusion criteria; (2) Pregnancy or breastfeeding; (3) Allergic to chemotherapy drugs and hypersensitivity; (4) With massive ascites; (5) Associated with lung, brain and other pelvic organ metastasis; (6) Receiving other anti-tumor drugs or radiotherapy; (7) Participate in other clinical trials or chemotherapy at the same time for less than 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| size of tumor; | — |
Countries
China
Contacts
Public ContactZeng Shue
Hubei Cancer Hospital
Outcome results
None listed